Canaccord analyst Kyle Mikson raised the firm’s price target on Natera (NTRA) to $150 from $145 and keeps a Buy rating on the shares. The firm said they are bullish heading into earnings and 2025 as recent weakness has provided an opportunity to accumulate shares ahead of upcoming catalysts or underappreciated positve factors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTRA:
- Natera price target raised to $150 from $140 at Leerink
- Craig-Hallum says buy CareDx as Natera drops pursuit of infringement claims
- Natera says court orders injunction against NeoGenomics’ accused RaDaR assay
- Natera price target raised to $150 from $135 at BTIG
- Natera announces new data from GALAXY arm of ongoing CIRCULATE-Japan trial